Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Reprogramming Of Cochlear Implant

Research Leaders

5 sponsors active, led by GE Healthcare

Related Conditions

Often studied with 9 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed2
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (3)

Research Network

Common Treatments

  • Reprogramming Of Cochlear Implant1
  • Fluency Shaping Exercises1

Active Sponsors

  • GE Healthcare1
  • Insel Gruppe AG, University Hospital Bern1
  • Alaa Mamdouh1
  • Göteborg University1
  • Vastra Gotaland Region1

Top Investigators

Related Conditions

  • Hearing1
  • Electroencephalography1
  • Deafness1
  • Cochlear Implants1
  • Deep Sedation1

Activity Timeline